Resistance to immunotherapy urothelial bladder cancer patients traced to specific sets of immune cells

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of the bladder have been identified and validated by researchers at Mount Sinai. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

As Ben Ho Park sees it, the mission of a cancer researcher doesn’t stop at the water’s edge. It follows that Park’s new role as director of Vanderbilt-Ingram Cancer Center is inseparable from his role as an executive of the Global Cancer Institute, a nonprofit that works with healthcare providers in low- and middle-income countries to improve survival rates for underserved cancer patients.

Login